Literature DB >> 30056577

Body mass index at the presentation of premature adrenarche is associated with components of metabolic syndrome at puberty.

Gamze Kaya1, Zehra Yavas Abali2, Firdevs Bas2, Sukran Poyrazoglu2, Feyza Darendeliler3.   

Abstract

The aim of this study was to analyze the relationship between premature adrenarche (PA) and metabolic syndrome (MeS) parameters at presentation and during puberty. This study comprised 47 girls with PA. Age- and puberty-matched 22 healthy girls without PA were the control group. Patients were evaluated at admission (first evaluation) and later in puberty (second evaluation). Anthropometric measurements, lipid levels, and hormonal parameters were studied and oral glucose tolerance test was performed. Indices for insulin resistance (IR) were calculated. The study group was divided in subgroups according to body mass index (BMI) and compared with the control group. The age of the PA group at first evaluation was 8.0 ± 1.1 years; mean height SDS and BMI SDS were 0.4 ± 1.2 and 0.6 ± 0.9, respectively. Age of PA group at the second evaluation was 12.9 ± 2.4 years. Frequency of obesity and overweight was 14.9 and 23.4%. Dyslipidemia ratio was 28.3%. PA group had significantly higher BMI than controls. Mean insulin concentration was higher and mean glucose and FGIR were lower in PA group and also dyslipidemia ratio was 5.3 times higher in PA than controls (p = 0.040). In PA group, overweight/obese subjects had still higher BMI at second evaluation and also higher fasting glucose, insulin, HOMA-IR. However, PA children with exaggerated DHEAS concentrations compared to those without had similar BMI SDS, insulin sensitivity, and secretion indices and lipid profile at second evaluation. BMI SDS at first evaluation was positively correlated with HOMA-IR at puberty; however, there is no correlation between DHEAS at first evaluation and HOMA-IR at puberty.
Conclusion: BMI at adrenarche is more important than prepubertal adrogen concentrations such as DHEAS, while predicting the IR in puberty. Long-term follow-up of children supports the observation that PA per se may be related to IR; however, the risk increases with obesity. What is Known: • Premature adrenarche (PA) is receiving more attention as evidence emerges for a relation between early androgen excess and metabolic syndrome. • The onset of the adrenal androgen production before 8 years in girls defined as PA. Pubarche, axillary hair, apocrine body odor, acne are typical phenotypic features of PA. What is New: • Body mass index at adrenarche is an important risk factor for development of insulin resistance in pubertal ages. • Degree of dehydroepiandrosterone sulfate elevation was not shown as a risk factor for insulin resistance.

Entities:  

Keywords:  Insulin resistance; Metabolic syndrome; Obesity; Premature adrenarche

Mesh:

Substances:

Year:  2018        PMID: 30056577     DOI: 10.1007/s00431-018-3211-1

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  26 in total

Review 1.  Premature adrenarche.

Authors:  Rachel M Williams; Caleb E Ward; Ieuan A Hughes
Journal:  Arch Dis Child       Date:  2011-08-11       Impact factor: 3.791

Review 2.  Clinical review: Identifying children at risk for polycystic ovary syndrome.

Authors:  Robert L Rosenfield
Journal:  J Clin Endocrinol Metab       Date:  2006-12-19       Impact factor: 5.958

3.  Incidence of ovulation in the years after the menarche.

Authors:  M G Metcalf; D S Skidmore; G F Lowry; J A Mackenzie
Journal:  J Endocrinol       Date:  1983-05       Impact factor: 4.286

4.  Approach to the girl with early onset of pubic hair.

Authors:  Sharon E Oberfield; Aviva B Sopher; Adrienne T Gerken
Journal:  J Clin Endocrinol Metab       Date:  2011-06       Impact factor: 5.958

Review 5.  Small for gestational age: short stature and beyond.

Authors:  Paul Saenger; Paul Czernichow; Ieuan Hughes; Edward O Reiter
Journal:  Endocr Rev       Date:  2007-02-23       Impact factor: 19.871

6.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

Authors:  M Matsuda; R A DeFronzo
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

7.  An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence.

Authors:  Lourdes Ibáñez; Sharon E Oberfield; Selma Witchel; Richard J Auchus; R Jeffrey Chang; Ethel Codner; Preeti Dabadghao; Feyza Darendeliler; Nancy Samir Elbarbary; Alessandra Gambineri; Cecilia Garcia Rudaz; Kathleen M Hoeger; Abel López-Bermejo; Ken Ong; Alexia S Peña; Thomas Reinehr; Nicola Santoro; Manuel Tena-Sempere; Rachel Tao; Bulent O Yildiz; Haya Alkhayyat; Asma Deeb; Dipesalema Joel; Reiko Horikawa; Francis de Zegher; Peter A Lee
Journal:  Horm Res Paediatr       Date:  2017-11-13       Impact factor: 2.852

8.  Hyperinsulinaemia, dyslipaemia and cardiovascular risk in girls with a history of premature pubarche.

Authors:  L Ibáñez; N Potau; P Chacon; C Pascual; A Carrascosa
Journal:  Diabetologia       Date:  1998-09       Impact factor: 10.122

9.  Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism.

Authors:  L Ibañez; N Potau; R Virdis; M Zampolli; C Terzi; M Gussinyé; A Carrascosa; E Vicens-Calvet
Journal:  J Clin Endocrinol Metab       Date:  1993-06       Impact factor: 5.958

Review 10.  Premature adrenarche: novel lessons from early onset androgen excess.

Authors:  Jan Idkowiak; Gareth G Lavery; Vivek Dhir; Timothy G Barrett; Paul M Stewart; Nils Krone; Wiebke Arlt
Journal:  Eur J Endocrinol       Date:  2011-05-26       Impact factor: 6.664

View more
  7 in total

Review 1.  Update on adrenarche.

Authors:  Selma Feldman Witchel; Bianca Pinto; Anne Claire Burghard; Sharon E Oberfield
Journal:  Curr Opin Pediatr       Date:  2020-08       Impact factor: 2.856

Review 2.  11-Oxygenated androgens in health and disease.

Authors:  Adina F Turcu; Juilee Rege; Richard J Auchus; William E Rainey
Journal:  Nat Rev Endocrinol       Date:  2020-03-16       Impact factor: 43.330

3.  Low prevalence of organic pathology in a predominantly black population with premature adrenarche: need to stratify definitions and screening protocols.

Authors:  Christy Foster; Alicia Diaz-Thomas; Amit Lahoti
Journal:  Int J Pediatr Endocrinol       Date:  2020-03-09

4.  Investigation of early puberty prevalence and time of addition thelarche to pubarche in girls with premature pubarche: two-year follow-up results.

Authors:  Esin Gizem Olgun; Sirmen Kizilcan Cetin; Zeynep Siklar; Zehra Aycan; Elif Ozsu; Aysegul Ceran; Merih Berberoglu
Journal:  Clin Pediatr Endocrinol       Date:  2021-11-01

5.  Cardiometabolic Risk Profile Among Young Adult Females With a History of Premature Adrenarche.

Authors:  Jani Liimatta; Pauliina Utriainen; Tomi Laitinen; Raimo Voutilainen; Jarmo Jääskeläinen
Journal:  J Endocr Soc       Date:  2019-07-15

6.  Salivary microbiome differences in prepubertal children with and without adrenal androgen excess.

Authors:  Brittany K Wise-Oringer; Anne Claire Burghard; Heekuk Park; Richard J Auchus; Sharon E Oberfield; Anne-Catrin Uhlemann
Journal:  Pediatr Res       Date:  2021-08-02       Impact factor: 3.953

7.  Predictive factors of polycystic ovary syndrome in girls with precocious pubarche.

Authors:  Valentina Guarnotta; Silvia Lucchese; Mariagrazia Irene Mineo; Donatella Mangione; Renato Venezia; Piero Luigi Almasio; Carla Giordano
Journal:  Endocr Connect       Date:  2021-07-21       Impact factor: 3.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.